Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies
-
By
-
Pupu Li
-
Xia Xue
-
Zisen Zhang
-
June 11, 2026
-
Clinical Scorecard: Mechanisms of Resistance and Strategies to Enhance CAR T-cell Therapy Efficacy in B-cell Hematologic Cancers
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | |
| Care Setting | Include specific clinical trial names or FDA-approved therapies. |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
- L
- i
- s
- t
-
- s
- p
- e
- c
- i
- f
- i
- c
-
- s
- e
- c
- o
- n
- d
- -
- g
- e
- n
- e
- r
- a
- t
- i
- o
- n
-
- C
- A
- R
-
- T
- -
- c
- e
- l
- l
-
- t
- h
- e
- r
- a
- p
- i
- e
- s
-
- b
- y
-
- n
- a
- m
- e
- .
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Provide specific data on complete remission rates for each malignancy type.
Clinical Best Practices
Related Resources & Content
